4//SEC Filing
ICOS CORP 4
Accession 0001181431-07-006912
CIK 0000874294operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:40 PM ET
Size
7.9 KB
Accession
0001181431-07-006912
Insider Transaction Report
Form 4
ICOS CORPICOS
Chang Shing
Senior VP, Drug Discovery
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-01-29$7.09/sh−49,500$350,955→ 0 totalExercise: $26.91From: 2006-10-09Exp: 2016-10-08→ Common Stock (49,500 underlying) - Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−16,500$561,000→ 0 total
Footnotes (3)
- [F1]Represents shares of restricted stock disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange $34.00 per share (the "Merger Consideration).
- [F2]The options vested monthly in 1/48th increments over four years (48 months) commencing on the grant date indicated.
- [F3]All options were cancelled pursuant to the Merger Agreement in exchange for cash consideration equal to the Merger Consideration less the exercise price per share.
Documents
Issuer
ICOS CORP
CIK 0000874294
Entity typeoperating
IncorporatedWA
Related Parties
1- filerCIK 0000874294
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 5:40 PM ET
- Size
- 7.9 KB